{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:52:53Z","timestamp":1725627173262},"reference-count":42,"publisher":"British Editorial Society of Bone & Joint Surgery","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/online.boneandjoint.org.uk\/TDM"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery. British volume"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:p>We studied 51 patients with osteo-articular tuberculosis who were divided into two groups. Group I comprised 31 newly-diagnosed patients who were given first-line antituberculous treatment consisting of isoniazid, rifampicin, ethambutol and pyrazinamide. Group II (non-responders) consisted of 20 patients with a history of clinical non-responsiveness to supervised uninterrupted antituberculous treatment for a minimum of three months or a recurrence of a previous lesion which on clinical observation had healed. No patient in either group was HIV-positive. Group II were treated with an immunomodulation regime of intradermal BCG, oral levamisole and intramuscular diphtheria and tetanus vaccines as an adjunct for eight weeks in addition to antituberculous treatment. We gave antituberculous treatment for a total of 12 to 18 months in both groups and they were followed up for a mean of 30.2 months (24 to 49). A series of 20 healthy blood donors served as a control group.<\/jats:p><jats:p>Twenty-nine (93.6%) of the 31 patients in group I and 14 of the 20 (70%) in group II had a clinicoradiological healing response to treatment by five months.<\/jats:p><jats:p>The CD4 cell count in both groups was depressed at the time of enrolment, with a greater degree of depression in the group-II patients (686 cells\/mm<jats:sup>3<\/jats:sup>(sd 261) and 545 cells\/mm<jats:sup>3<\/jats:sup>(sd 137), respectively; p &lt; 0.05). After treatment for three months both groups showed significant elevation of the CD4 cell count, reaching a level comparable with the control group. However, the mean CD4 cell count of group II (945 cells\/mm<jats:sup>3<\/jats:sup>(sd 343)) still remained lower than that of group I (1071 cells\/mm<jats:sup>3<\/jats:sup>(sd 290)), but the difference was not significant. Our study has shown encouraging results after immunomodulation and antituberculous treatment in non-responsive patients. The pattern of change in the CD4 cell count in response to treatment may be a reliable clinical indicator.<\/jats:p>","DOI":"10.1302\/0301-620x.88b2.17197","type":"journal-article","created":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T18:48:46Z","timestamp":1138128526000},"page":"264-269","source":"Crossref","is-referenced-by-count":14,"title":["The use of immunomodulators as an adjunct to antituberculous chemotherapy in non-responsive patients with osteo-articular tuberculosis"],"prefix":"10.1302","volume":"88-B","author":[{"given":"A.","family":"Arora","sequence":"first","affiliation":[{"name":"University College of Medical Sciences and GTB Hospital, Shahdara, Delhi-110095, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"University College of Medical Sciences and GTB Hospital, Shahdara, Delhi-110095, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dev","sequence":"additional","affiliation":[{"name":"University College of Medical Sciences and GTB Hospital, Shahdara, Delhi-110095, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chattopadhya","sequence":"additional","affiliation":[{"name":"National Institute of Communicable Diseases, 22 Shamnath Marg, New Delhi-110054, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Jain","sequence":"additional","affiliation":[{"name":"University College of Medical Sciences and GTB Hospital, Shahdara, Delhi-110095, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Tuli","sequence":"additional","affiliation":[{"name":"VIMHANS, Nehru Nagar, New Delhi-110065, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kumar","sequence":"additional","affiliation":[{"name":"University College of Medical Sciences and GTB Hospital, Shahdara, Delhi-110095, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"42","reference":[{"key":"R1","unstructured":"Talavera W, Miranda R, Lessnau KKL, Klapholz A.Extrapulmonary tuberculosis. In: Friedman LN, ed.Tuberculosis: current concepts and treatment. Second ed. New York CRC Press, 2001."},{"key":"R2","unstructured":"World Health Organisation.Antituberculosis drug resistance in the world. In:The WHO\/UATLD global project on drug resistance surveillance 1994\u20131997. Geneva: Switzerland, 1997:1\u2013227."},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(87)90055-9"},{"key":"R4","unstructured":"Beck JS, Potts RC, Kardjito T, Grange JM.T4 lymphopenia in patients with active pulmonary tuberculosis. Clin Exp Immunol 1985;60:49\u201354."},{"key":"R5","unstructured":"Khomenko AG, Averbach MM, Litvinov VI, Gergert VJ, Chukanov VI.Effect of chemotherapy in the immunological characteristics of patients with primary destructive pulmonary tuberculosis. Bull World Health Organ 1984;62:763\u201371."},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(89)90047-0"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Bose M, Gupta A, Banavalikar JN, Saha K.Dysregulation of homeostasis of blood T lymphocyte subpopulations persists in chronic multibacillary pulmonary tuberculosis patients refractory to treatment. Tuber Lung Dis 1995;76:59\u201364.","DOI":"10.1016\/0962-8479(95)90581-2"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.76.6.741"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Second East African\/British Medical Research Council Report.Controlled clinical trial of four short course (6 months) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1974;1:1100\u20138.","DOI":"10.1016\/S0140-6736(74)90868-X"},{"key":"R10","unstructured":"Stanford JL, Bahr GM, Byass P, et al.A modern approach to the immunotherapy of tuberculosis. Bull Int Union Tuberc Lung Dis 1990;65:27\u20139."},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Eternadi A, Farid R, Stanford JL.Immunotherapy for drug resistant tuberculosis. Lancet 1992;340:1360\u20131.","DOI":"10.1016\/0140-6736(92)92551-P"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Martinez D, Zaias N.Levamisole as an adjunct to dapsone in leprosy. Lancet 1976; 2:209\u201310.","DOI":"10.1016\/S0140-6736(76)92396-5"},{"key":"R13","unstructured":"Kazura JW, Hegendank W, Guerry D, Schreiber AD.Human monocyte lymphocyte interaction and its enhancement by levamisole. Clin Exp Immunol 1979;35:258\u201368."},{"key":"R14","unstructured":"Verhaegen H, De Cree J, De Cock W, Verbruggen F.Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases. Clin Exp Immunol 1977;27:313\u201318."},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(99)90204-4"},{"key":"R16","unstructured":"Ishibashi T, Harada S, Takamoto M, et al.Mode of immunopotentiating action of BCG: macrophage activation produced by BCG-infection. Jpn J Exp Med 1978;48: 35\u201340."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-200205000-00003"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90537-4"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1179\/027249303225007824"},{"key":"R20","unstructured":"Tuli SM.Tuberculosis of the skeletal system. Second ed. New Delhi: Jaypee Brothers Medical Publishers, 1997:47\u201356."},{"key":"R21","unstructured":"Chaudhury S, Hazra SK, Saha B, et al.An eight year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis. Int J Lepr 1994;62:389\u201394."},{"key":"R22","unstructured":"Choudhury S, Hazra SK, Mukherjee A, et al.Immunotherapy of lepromin-negative borderline leprosy patients with low-dose convit vaccine as an adjuvant to multi-drug therapy: a six year follow-up study in Calcutta. Int J Lepr 1997;1:56\u201362."},{"key":"R23","unstructured":"Glassroth J.Diagnosis of tuberculosis. In: Reichman LB, Hershfield ES, eds.Tuberculosis: a comprehensive international approach. New York: Raven Press, 1994: 149\u201365."},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Gillespie WJ.Epidemiology in bone and joint infection. Infect Dis Clin North Am 1990;4:361\u201376.","DOI":"10.1016\/S0891-5520(20)30351-2"},{"key":"R25","unstructured":"Aggarwal RP, Mohan N, Garg RK, et al.Clinicosocial aspects of osteoarticular tuberculosis. J Indian Med Assoc 1990;88:307\u20139."},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.56B4.760"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01438-8"},{"key":"R28","unstructured":"Somoskovi A, Zissel G, Zipfel PF, et al.Different cytokine patterns correlate with the extension of the disease in pulmonary tuberculosis. Eur Cytokine Netw 1999;10: 135\u201342."},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199111000-00004"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1007\/s002640000125"},{"key":"R31","unstructured":"Youmans GP.Mechanisms of immunity of tuberculosis. Pathobiol Annu 1979;9: 137\u201362."},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1988.tb00964.x"},{"key":"R33","unstructured":"Morris CD, Bird AR, Nell H.The haematological and biochemical changes in severe tuberculosis. Q J Med 1989;73:1151\u20139."},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Chandra RK.Nutrition, immunity and infection: present knowledge and future direction. Lancet 1983;1:688\u201391.","DOI":"10.1016\/S0140-6736(83)91980-3"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199301000-00008"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.3.725"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(90)90038-A"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(99)90155-5"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.7.2472"},{"key":"R40","unstructured":"Standford JL, Grange JM.New concepts for the control of tuberculosis in the twenty first century. J R Coll Phy 1993;27:218\u201323."},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Ravn P, Boesen P, Pedersen BK, Andersen P.Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 1997; 158:1949\u201355.","DOI":"10.4049\/jimmunol.158.4.1949"},{"key":"R42","unstructured":"Tuli SM.Preliminary observations of the effect of immuno-modulation in multi-drug resistant cases of osteo-articular tuberculosis. Ind J Orthop 1999;33:83\u20135."}],"container-title":["The Journal of Bone and Joint Surgery. British volume"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/0301-620X.88B2.17197","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/full-xml\/10.1302\/0301-620X.88B2.17197","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/0301-620X.88B2.17197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T08:28:11Z","timestamp":1683361691000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/10.1302\/0301-620X.88B2.17197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1302\/0301-620X.88B2.17197"],"URL":"https:\/\/doi.org\/10.1302\/0301-620x.88b2.17197","relation":{},"ISSN":["0301-620X","2044-5377"],"issn-type":[{"value":"0301-620X","type":"print"},{"value":"2044-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}